In cancer cells, oncogenic tyrosine kinases (BCR-ABL, JAK2) are highly expressed and perform tyrosine phosphorylation of pyruvate dehydrogenase kinase 1 (PDHK1). This evidence concerns the gene JAK2 and cancer.